Donor Landscaping Report: Rectal artesunate
Mortality rate is predicted to be 90% at home and 20% in hospitals every hour a patient goes without medication is crucial. 70% of deaths in children in 2015 (2015: 303.000 / 445.000 ). Rectal artesunate (RAS) gives severe malaria patients <6 years who have difficulty reaching a health facility for treatment <6 hours an initial dose of artesunate to slow the rate at which severe malaria progresses. The Global technical strategy and targets for malaria 2016–2030 is to decrease malaria incidence and mortality by 90%. Artesunate Rectal Capsules can help achieve this goal by helping to prevent mortality caused by severe malaria.